Cargando…

A real-world intention-to-treat analysis of a decade’s experience of treatment of hepatitis C with interferon-based therapies

Objectives: To assess the uptake of pegylated interferon (PegIFN) plus ribavirin (RBV)-based regimens in patients with hepatitis C virus (HCV) in a large, single-centre, real-world setting over 10 years. Methods: This was a single centre, retrospective analysis of data from patients who attended the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Selvapatt, Nowlan, Brown, Ashley
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	F1000Research 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5034792/ https://www.ncbi.nlm.nih.gov/pubmed/27746906 http://dx.doi.org/10.12688/f1000research.9114.1

Ejemplares similares

Real World Experience of Chronic Hepatitis C Retreatment with Genotype Specific Regimens in Nonresponders to Previous Interferon-Free Therapy
por: Zarębska-Michaluk, Dorota, et al.
Publicado: (2019)

Real-world experience with interferon-free, direct acting antiviral therapies in Asian Americans with chronic hepatitis C and advanced liver disease
por: Chang, Christine Y., et al.
Publicado: (2017)

Revisional Laparoscopic Parastomal Hernia Repair
por: Zacharakis, Emmanouil, et al.
Publicado: (2008)

Real world experience with pegylated interferon and ribavirin in hepatitis C genotype 1 population with favourable IL28B polymorphism
por: Ekstrom, Victoria, et al.
Publicado: (2017)

More than a decade of real-world experience of pegvisomant for acromegaly: ACROSTUDY
por: Fleseriu, Maria, et al.
Publicado: (2021)

Real‐world experience for the outcomes and costs of treating hepatitis C patients: Results from the German Hepatitis C-Registry (DHC-R)
por: Krüger, Kathrin, et al.
Publicado: (2022)

Sofosbuvir-Based Therapies for Patients with Hepatitis C Virus Infection: Real-World Experience in China
por: Hu, Chengguang, et al.
Publicado: (2018)

Interferon-free treatments in patients with hepatitis C genotype 1-4 infections in a real-world setting
por: Ramos, Huascar, et al.
Publicado: (2017)

Effect of pegylated interferon-α2b add-on therapy on renal function in chronic hepatitis B patients: A real-world experience
por: Peng, Mei-Juan, et al.
Publicado: (2022)

Safety of Patients with Hepatitis C Virus Treated with Glecaprevir/Pibrentasvir from Clinical Trials and Real-World Cohorts
por: Forns, Xavier, et al.
Publicado: (2021)

Real-world Experiences in the Transplantation of Hepatitis C-NAAT–positive Organs
por: Steinbrink, Julie M., et al.
Publicado: (2023)

Efficacy of fecal microbiota therapy in steroid dependent ulcerative colitis: a real world intention-to-treat analysis
por: Sood, Ajit, et al.
Publicado: (2019)

Real-World Evidence of EGFR Targeted Therapy in NSCLC– A Brief Report of Decade Long Single Center Experience
por: Chougule, Anuradha, et al.
Publicado: (2023)

Adjuvant therapy of melanoma with interferon: lessons of the past decade
por: Ascierto, Paolo A, et al.
Publicado: (2008)

Histological improvement in chronic hepatitis B patients treated with bicyclol: real world experience
por: Chi, Xiaoling, et al.
Publicado: (2019)

Quality of life of Brazilian chronic hepatitis C patients treated with interferon-free therapies
por: Siqueira, Fabiane Mateus, et al.
Publicado: (2018)

Hepatitis Virus Reactivation in Patients with Psoriasis Treated with Secukinumab in a Real-World Setting of Hepatitis B or Hepatitis C Infection
por: Megna, Matteo, et al.
Publicado: (2022)

Eligibility and Safety of Triple Therapy for Hepatitis C: Lessons Learned from the First Experience in a Real World Setting
por: Maasoumy, Benjamin, et al.
Publicado: (2013)

Real-World Experience of Treating Chronic Obstructive Pulmonary Disease with Triple Therapy
por: Liao, Kuang-Ming, et al.
Publicado: (2023)

Real-World Experience of Chronic Hepatitis C-Related Compensated Liver Cirrhosis Treated with Glecaprevir/Pibrentasvir: A Multicenter Retrospective Study
por: Su, Pei-Yuan, et al.
Publicado: (2021)

Predictors of response to pegylated interferon in chronic hepatitis B: a real-world hospital-based analysis
por: Wang, Yin-Chen, et al.
Publicado: (2016)

Real-World Evidence in Glioblastoma: Stupp's Regimen After a Decade
por: Lakomy, Radek, et al.
Publicado: (2020)

Evolution of Interferon-Based Therapy for Chronic Hepatitis C
por: Chen, Chun-Hao, et al.
Publicado: (2010)

Hyercalcemia induced by interferon therapy in chronic hepatitis C
por: Albaker, Waleed I.
Publicado: (2012)

Evaluation of health status in patients with hepatitis c treated with and without interferon
por: Ragusa, R., et al.
Publicado: (2018)

Experiences with interferon-free hepatitis C therapies: addressing barriers to adherence and optimizing treatment outcomes
por: Skolnik, Avy A., et al.
Publicado: (2019)

A platform in the use of medicines to treat chronic hepatitis C (PLATINUM C): protocol for a prospective treatment registry of real-world outcomes for hepatitis C
por: Ramsay, Jessica, et al.
Publicado: (2020)

The impact of ribavirin on real-world adherence rates in hepatitis C patients treated with sofosbuvir plus simeprevir
por: Walker, David R, et al.
Publicado: (2015)

Real-World Outcomes in Historically Underserved Patients with Chronic Hepatitis C Infection Treated with Glecaprevir/Pibrentasvir
por: Aghemo, Alessio, et al.
Publicado: (2021)

Effectiveness of Glecaprevir/Pibrentasvir for Hepatitis C: Real-World Experience and Clinical Features of Retreatment Cases
por: Sugiura, Ayumi, et al.
Publicado: (2020)

Thrombotic Thrombocytopenic Purpura in a Patient with Interferon Treated Hepatitis C Successfully Treated with Rituximab
por: Poddar, Nishant, et al.
Publicado: (2013)

Do seasonal-to-decadal climate predictions underestimate the predictability of the real world?
por: Eade, Rosie, et al.
Publicado: (2014)

Interferon-alpha-induced sarcoidosis in a patient being treated for hepatitis C
por: Trien, Remi, et al.
Publicado: (2014)

Interferons and Multiple Sclerosis: Lessons from 25 Years of Clinical and Real-World Experience with Intramuscular Interferon Beta-1a (Avonex)
por: Cohan, Stanley L., et al.
Publicado: (2021)

354 Autoimmune Hepatitis Misdiagnosed as Hepatitis C Responding to Interferon/Ribavirine Therapy
por: Pijak, Michal R., et al.
Publicado: (2012)

Thyroid Dysfunction in Non-Interferon Treated Hepatitis C Patients Residing in Hepatitis Endemic Area
por: Batool, Nayab, et al.
Publicado: (2017)

Retinopathy associated with interferon therapy in patients with hepatitis C virus
por: Abd El-Badie Mohamed, Mahmoud, et al.
Publicado: (2012)

Real-World Experience Treating Pediatric Epilepsy Patients With Cenobamate
por: Makridis, Konstantin L., et al.
Publicado: (2022)

Thyroid Peroxidase Antibodies in Non-Interferon Treated Hepatitis C Patients in Pakistan
por: Shafiq, Muhammad Imtiaz, et al.
Publicado: (2015)

Cost Effectiveness and Cost Containment in the Era of Interferon-Free Therapies to Treat Hepatitis C Virus Genotype 1
por: Linas, Benjamin P., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_k12v8vgbu634phbsigj12v3pon